Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2005. Start Trial.
Date Value
November 17, 2026 4.671
November 16, 2026 4.671
November 13, 2026 4.833
November 12, 2026 4.833
November 11, 2026 4.833
November 10, 2026 4.833
November 09, 2026 4.833
November 06, 2026 4.758
November 05, 2026 4.758
November 04, 2026 4.553
November 03, 2026 4.553
November 02, 2026 4.964
October 30, 2026 4.964
October 29, 2026 4.964
October 28, 2026 5.006
October 27, 2026 6.092
October 26, 2026 6.092
October 23, 2026 6.092
October 22, 2026 6.092
October 21, 2026 6.092
October 20, 2026 6.092
October 19, 2026 6.092
October 16, 2026 6.092
October 15, 2026 6.092
October 14, 2026 6.092
Date Value
October 13, 2026 6.092
October 12, 2026 6.092
October 09, 2026 6.092
October 08, 2026 6.092
October 07, 2026 6.092
October 06, 2026 6.092
October 05, 2026 6.092
October 02, 2026 6.092
October 01, 2026 6.092
September 30, 2026 6.092
September 29, 2026 5.72
September 28, 2026 5.72
September 25, 2026 5.72
September 24, 2026 5.72
September 23, 2026 5.72
September 22, 2026 5.72
September 21, 2026 5.72
September 18, 2026 5.72
September 17, 2026 5.72
September 16, 2026 5.72
September 15, 2026 5.72
September 14, 2026 5.72
September 11, 2026 5.72
September 10, 2026 5.72
September 09, 2026 5.72

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Oryzon Genomics SA 2.015
Grifols SA 0.8882
ACADIA Pharmaceuticals, Inc. 2.275
Alkermes Plc 4.189
Alnylam Pharmaceuticals, Inc. 5.814

Price to Book Value Related Metrics